Cited by 227Atherosclerosis and Cardiovascular DiseasesNitric Oxide and Endothelin EffectsLipoproteins and Cardiovascular Health

Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism

Doi, Hideki, Kugiyama, Kiyotaka, Oka, Hideki, Sugiyama, Seigo, Ogata, Nobuhiko, Koide, Shun-ichi, Nakamura, Shin-ichi, Yasue, Hirofumi·2000·Circulation

Abstract

Background —Triglyceride-rich lipoproteins (TGLs) are atherogenic. However, their cellular mechanisms remain largely unexplained. This study examined the effects of isolated remnant-like lipoprotein particles (RLPs) on the expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and tissue factor (TF), proatherothrombogenic molecules, in cultured human endothelial cells. Methods and Results —RLPs were isolated from plasma of hypertriglyceridemic patients by use of the immunoaffinity gel mixture of anti–apoA-1 and anti–apoB-100 monoclonal antibodies. The incubation of cells with RLPs significantly upregulated mRNA and protein expression of these molecules. Total TGLs ( d <1.006) and LDL had fewer or minimal effects on expression of these molecules compared with RLPs. RLPs increased intracellular oxidant levels, as assessed with an oxidant-sensitive probe. Combined incubation with α-tocopherol or N -acetylcysteine, both antioxidants, suppressed RLP-induced increase in expression of these molecules. In patients with higher plasma levels of RLPs, plasma levels of soluble forms of ICAM-1 and VCAM-1 were significantly higher than in patients with lower RLP levels. Treatment with α-tocopherol for 1 month decreased levels of the soluble adhesion molecules concomitantly with an increase in resistance of RLPs to oxidative modification in patients with high RLP levels. Conclusions —RLPs upregulated endothelial expression of ICAM-1, VCAM-1, and TF, proatherothrombogenic molecules, partly through a redox-sensitive mechanism. RLPs may have an important role in atherothrombotic complications in hypertriglyceridemic patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.102.6.670

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TRL remnants contribute to a prothrombotic phenotype by promoting platelet activation and aggregation and modulating endothelial and systemic hemostatic responses.

    “In addition, TRL remnants contribute to a prothrombotic phenotype within the vascular wall by promoting platelet activation and aggregation, and by modulating both endothelial and systemic hemostatic responses [29–32].”

    From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [29]

    The Discussion (page not indicated) reports that remnant-like lipoproteins increased endothelial tissue factor expression, supporting an endothelial prothrombotic effect. It also reports higher circulating soluble adhesion molecules in patients with higher remnant levels, but does not show platelet activation or aggregation or establish a systemic hemostatic response. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • TRL remnants increase expression of plasminogen activator inhibitor-1 (PAI-1), impairing fibrinolytic activity, leading to reduced clot resolution and enhanced thrombus persistence.

    “Moreover, remnants have been shown to increase the expression of plasminogen activator inhibitor-1 (PAI-1), the primary inhibitor of tissue plasminogen activator (tPA), thereby impairing fibrinolytic activity. Elevated PAI-1 levels lead to reduced clot resolution capacity and have been associated with enhanced thrombus persistence, particularly at sites of plaque disruption [29, 30].”

    From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [29]

    The Discussion (page unavailable) reports that remnant-like particles increased endothelial tissue factor, ICAM-1, and VCAM-1, but does not address PAI-1, fibrinolytic activity, clot resolution, or thrombus persistence. A work listed in the References concerns PAI-1 and oxidized LDL, not remnant lipoproteins. Searches for PAI-1 and fibrinolysis found no passage supporting the attributed mechanism. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 23 · Cited by 227

Research works printed but not linked: 23

  1. Hodis HN, Mack WJ, Azen SP, et al. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a con- trolled trial of lovastatin. Circulation. 1994;90:42-49.
  2. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 1993;88:2762-2770.
  3. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
  4. Doi H, Kugiyama K, Ohgushi M, et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasore- laxation. Atherosclerosis. 1998;137:341-349.
  5. Kugiyama K, Doi H, Motoyama T, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation. 1998;97:2519 -2526.
  6. Kugiyama K, Doi H, Takazoe K, et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 1999;99:2858 -2860.
  7. Griendling KK, Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J. 1996;10:283-292.
  8. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;25: 788 -791.
  9. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell- mediated thrombogenicity in acute coronary syndromes. Circulation. 1996;94:3090 -3097.
  10. Nakajima K, Okazaki M, Tanaka A, et al. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-1. J Clin Ligand Assays. 1996;19:177-183.
  11. Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18:723-731.
  12. Kugiyama K, Sakamoto T, Misumi I, et al. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res. 1993;73:335-343.
  13. Khan BV, Parthasarathy SS, Alexander RW, et al. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 1995;95:1262-1270.
  14. Engelmann B, Zieseniss S, Brand K, et al. Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. Arterioscler Thromb Vasc Biol. 1999;19:47-53.
  15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Labo- ratory Press; 1989.
  16. Sugiyama S, Kugiyama K, Ogata N, et al. Biphasic regulation of tran- scription factor nuclear factor-B activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol. 1998;18:568 -576.
  17. Bass DA, Parce JW, Dechatelet LR, et al. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910 -1917.
  18. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 1994;233:425-441.
  19. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219 -4225.
  20. Chiu D, Kuypers F, Lubin B. Lipid peroxidation in human red cells. Semin Hematol. 1989;26:257-276.
  21. Frei B. Reactive oxygen species and antioxidant vitamins: mechanism of action. Am J Med. 1994;97:5S-13S.
  22. Mackman N. Regulation of the tissue factor gene. FASEB J. 1995;9: 883-889.
  23. Tomono S, Kawazu S, Kato N, et al. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Ath- eroscler Thromb. 1994;1:98 -102.

Authors
Doi, H., Kugiyama, K., Oka, H., Sugiyama, S., Ogata, N., Koide, S.-I., Nakamura, S.-I., & Yasue, H.
Affiliations
  • Kumamoto University (JP)
  • From the Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto City, Japan.
Venue
Circulation
Published
2000-08-08
Volume
102
Issue
6
Pages
670-676
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2060719440
Cited by
227
References
23
Citations by year
2026: 10 · 2025: 11 · 2024: 9 · 2023: 15 · 2022: 11 · 2021: 12 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 2 · 2014: 11 · 2013: 7 · 2012: 9
FWCI
3.50
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
Smoking Research Foundation
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
triglyceride-rich lipoproteins, endothelial cells, ICAM-1, VCAM-1, tissue factor, adhesion molecules, oxidative stress, redox signaling, hypertriglyceridemia, alpha-tocopherol, N-acetylcysteine, atherothrombosis, lipoprotein oxidation
MeSH terms
Arteriosclerosis, Cells, Cultured, Culture Media, DNA, Endothelium, Vascular, Humans, Lipid Peroxides, Lipoproteins, Oxidation-Reduction, Peptide Fragments, RNA, Messenger, Solubility, Thromboplastin, Vitamin E, Hypertriglyceridemia, NF-kappa B, Intercellular Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review